Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas

被引:120
作者
Saito, T
Endo, T
Kawaguchi, A
Ikeda, M
Katoh, R
Kawaoi, A
Muramatsu, A
Onaya, T [1 ]
机构
[1] Yamanashi Med Univ, Dept Internal Med 3, Tamaho, Yamanashi 40938, Japan
[2] Yamanashi Med Univ, Dept Pathol, Tamaho, Yamanashi 40938, Japan
[3] Kofu City Hosp, Dept Surg, Kofu, Yamanashi 400, Japan
关键词
iodide transport; radioiodine treatment; Na+/I- symporter; immunohistochemistry;
D O I
10.1172/JCI1259
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Iodide is concentrated to a much lesser extent by papillary thyroid carcinoma as compared with the normal gland, The Na+/I- symporter (NIS) is primarily responsible for the uptake of iodide into thyroid cells, Our objective was to compare NIS mRNA and protein expression in papillary carcinomas with those in specimens with normal thyroid, Northern blot analysis revealed a 2.8-fold increase in the level of NIS mRNA in specimens with papillary carcinoma versus specimens with normal thyroid. Immunoblot analysis using anti-human NIS antibody that tvas produced with a glutathione S-transferase fusion protein containing NIS protein (amino acids 466-522) showed the NIS protein at 77 kD. The NIS protein level was elevated in 7 of 17 cases of papillary carcinoma but was not elevated in the normal thyroid, Immunohistochemical staining revealed abundant NIS in 8 of 12 carcinomas, whereas NIS protein was barely detected in specimens with normal thyroid, Although considerable patient-to-patient variation was observed, our results indicate that NIS mRNA is elevated, and its protein tends to be more abundant, in a subset of papillary thyroid carcinomas than in normal thyroid tissue.
引用
收藏
页码:1296 / 1300
页数:5
相关论文
共 35 条
[1]  
ABE Y, 1977, LANCET, V2, P506
[2]  
ARCANGELI P, 1981, CANCER, V48, P757, DOI 10.1002/1097-0142(19810801)48:3<757::AID-CNCR2820480316>3.0.CO
[3]  
2-V
[4]  
BEIERWALTES WH, 1986, WERNERS THYROID, P1319
[5]   HUMAN THYROID-CANCER - MEMBRANE THYROTROPIN BINDING AND ADENYLATE-CYCLASE ACTIVITY [J].
CARAYON, P ;
THOMASMORVAN, C ;
CASTANAS, E ;
TUBIANA, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (04) :915-920
[6]  
CHARKES ND, 1986, WERNERS THYROID, P458
[7]  
CRILE G, 1971, SURG GYNECOL OBSTETR, V132, P460
[8]   Cloning and characterization of the thyroid iodide transporter [J].
Dai, G ;
Levy, O ;
Carrasco, N .
NATURE, 1996, 379 (6564) :458-460
[9]   IDENTIFICATION OF COLD THYROID LESIONS AT OPERATION AND ITS PLACE IN SURGICAL MANAGEMENT OF CARCINOMA OF THYROID [J].
DOBYNS, BM ;
BERTOZZI, G .
ANNALS OF SURGERY, 1970, 172 (04) :703-&
[10]   MEASUREMENT OF SERUM TSH AND THYROID-HORMONES IN MANAGEMENT OF TREATMENT OF THYROID-CARCINOMA WITH RADIOIODINE [J].
EDMONDS, CJ ;
KERMODE, JC ;
HAYES, S ;
THOMPSON, BD .
BRITISH JOURNAL OF RADIOLOGY, 1977, 50 (599) :799-807